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2 
Abstract  1 
Carbon nanotubes (CNTs) have many interesting properties. In particular, their 2 
photohyperthermic effect by near-infrared (NIR) irradiation could be used to kill cancer cells, 3 
and could thus be applied in photohyperthermic therapy. However, the solubility of CNTs must 4 
be improved before they can be used in biological applications. As DNA is reported to disperse 5 
the CNTs in aqueous solution with π–π interactions, we hypothesis that immunostimulatory CpG 6 
DNA may also disperse the CNTs in aqueous solution. In this study, we used CpG DNA to 7 
disperse single-walled CNTs (SWCNTs) in aqueous solution, in order to combine 8 
photohyperthermic effect and immunoactivation together to achieve a more effective cancer 9 
therapy. As expected, CpG DNA effectively dispersed the SWCNTs in aqueous solution via the 10 
formation of SWCNT/CpG DNA complexes. Moreover, the immunoreactivity of the 11 
SWCNT/CpG DNA complexes was investigated. The results showed that intratumoral 12 
administration of the SWCNT/CpG DNA complexes in mice enhanced the production level of 13 
inflammatory cytokines in tumor tissues. Finally, we evaluated the antitumor effects of the 14 
SWCNT/CpG DNA complexes in tumor-bearing mice. The result indicated that intratumoral 15 
administration of the SWCNT/CpG DNA complexes combined with NIR irradiation was a more 16 
effective approach to prevent the proliferation of tumor growth.  17 
 18 
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3 
1. Introduction 1 
Carbon nanotubes (CNTs) consist exclusively of carbon atoms arranged in condensed 2 
aromatic rings, which in turn are organized in one (single-walled carbon nanotube: SWCNT) 3 
(Iijima and Ichihashi, 1993) or more (multi-walled carbon nanotube) (Iijima, 1991) concentric 4 
graphene sheets rolled-up into cylinders. The diameters of the CNTs range from a few 5 
nanometers to hundreds of nanometers. Owing to their unique structural and electronic 6 
properties, CNTs have various possibilities for application in nanomedicine as biocompatible 7 
materials for developing versatile drugs (Allen and Cullis, 2004; Bianco et al., 2005a), proteins 8 
(Kam and Dai, 2005; Kam et al., 2004), genes (Cai et al., 2005; Liu et al., 2005), and vaccine 9 
delivery systems (Panhuis, 2003). Especially, CNTs have a strong optical absorption in the near-10 
infrared (NIR) region and can release this energy within tissue to produce localized heating 11 
(Chakravarty et al., 2008; Kam et al., 2005). Therefore, CNTs may be promising 12 
photohyperthermic therapy agents for cancer therapy, because the selective thermal ablation of 13 
malignant tissue is an important objective in cancer research and offers a viable alternative 14 
treatment option when surgical resection is not possible (DeNardo GL and DeNardo SJ, 2008).  15 
However, CNTs are completely insoluble in most organic solvents and aqueous buffers. 16 
Indeed, since the time when CNTs were first produced, there has much interest, particularly in 17 
the domain of biological and biomedical research, in enhancing the dispersibility and/or 18 
solubility of CNTs in aqueous solution to overcome this important problem. It has been reported 19 
that many detergents, such as sodium dodecyl benzene sulfonate and Triton-X100, are able to 20 
  
4 
disperse CNTs, but these detergents are generally toxic to normal cells (Dong et al., 2009). To 1 
resolve this problem, several approaches to functionalize CNTs, including defect-group 2 
chemistry, covalent sidewall chemistry, non-covalent wrapping by polymers, biopolymers, 3 
surfactants and other amphiphilic molecules, have been explored (Heister et al., 2010; 4 
Mackiewicz et al., 2008; Shim and Ahn, 2012; Stranks et al., 2012; Tasis et al., 2006;). More 5 
recently, Zheng et al. reported that DNA can disperse CNTs in aqueous solution, where the 6 
aromatic nucleotide bases in DNA are suggested to interact with the CNTs through π-π stacking 7 
(Hughes et al., 2007; Zheng et al., 2003a). Therefore, we considered that immunostimulatory 8 
CpG DNA, which is capable of activating the immune system (Krieg, 2002), may be expected to 9 
interact with CNTs to improve the dispersibility of the CNTs. Moreover, the immune responses 10 
elicited by CpG DNA have the potential to inhibit tumor growth. In our previous studies, we 11 
formulated complexes of phosphorothioate-type CpG DNA with cationic liposomes, and the 12 
complexes showed strong immune responses and were effective in preventing proliferation of 13 
cancer cells (Kuramoto et al., 2009, 2008; Zhou et al., 2012, 2010). Therefore, the combination 14 
of photohyperthermic therapy and immunotherapy could be an effective approach for cancer 15 
therapy.  16 
In this study, we used CpG DNA to disperse SWCNTs via the formation of SWCNT/CpG 17 
DNA complexes. It is suggested that these SWCNT/CpG DNA complexes may possess not only 18 
a photohyperthermic effect, but also an immunostimulatory effect. First, we obtained the results 19 
  
5 
that CpG DNA dispersed the SWCNTs in aqueous solution individually. Then, the 1 
photohyperthermic effects of the SWCNT/CpG DNA complexes were observed in vitro and in 2 
vivo with NIR laser irradiation. In addition, the SWCNT/CpG DNA complexes induced high 3 
levels of inflammatory cytokine production in serum and in tumor tissues when intratumorally 4 
administrated to colon 26 tumor-bearing mice. Furthermore, the SWCNT/CpG DNA complexes 5 
when irradiated with NIR laser, significantly inhibited tumor growth in colon 26 tumor-bearing 6 
mice. Thus, SWCNT/CpG DNA complexes with NIR laser irradiation would be an effective 7 




2. Material and Methods 1 
2.1 Oligonucleotides 2 
Oligonucleotides with phosphorothioate backbones were purchased from Operon (Tokyo, 3 
Japan). The sequences of the oligonucleotides were 5’-4 
TCGACGTTTTGACGTTTTGACGTTTT-3’ (CpG DNA) and 5’-5 
TGCAGCTTTTGAGCTTTTGAGCTTTT-3’ (GpC DNA). 6 
2.2 Cell lines 7 
Murine adenocarcinoma colon 26 tumor cells (Zhou et al., 2010) were grown in 5% CO2 in 8 
humidified air at 37 °C with RPMI1640 medium (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) 9 
supplemented with 10% fetal bovine serum (MP Biomedicals, Inc., Irvine, CA, USA), 100 IU/ml 10 
penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine.  11 
2.3 Animals 12 
Male BALB/c (5-week-old) mice were purchased from the Shizuoka Agricultural 13 
Cooperative Association for Laboratory Animals (Shizuoka, Japan). All the animals were housed 14 
with free access to food and water. The light (dark/light cycle was 12/12 h), temperature, and 15 
humidity were kept constant throughout the experiments. All animal experiments were approved 16 
  
7 
by the Animal Experimentation Committee of the Graduate School of Pharmaceutical Sciences, 1 
Kyoto University. 2 
2.4 Preparation of SWCNT/CpG DNA complex 3 
One milligram of HiPco SWCNTs (containing 9 wt% of TGA Residue as Fe(iv) from the 4 
manufacturer information, Carbon Nanotechnologies Incorporated) and 5 mg of CpG DNA 5 
(Operon, Tokyo, Japan) were sonicated in 5 ml of 5% dextrose solution for 20 minutes in an ice-6 
water bath by the formation of complexes (SWCNT/CpG DNA complexes).  7 
2.5 Evaluation of the amount of CpG DNA that’s bound to the SWCNTs.  8 
The amount of CpG DNA adsorbing to SWCNTs surface was determined by 9 
spectrophotometically. The SWCNTs suspension complexed with CpG DNA was filtrated with 10 
0.22 um centrifugal filter device (Ultrafree-MC, Merck Millipore, Darmstadt, Germany) to 11 
remove free CpG DNA witch dose not bind to SWCNTs. Filtrated SWCNTs was resuspended 12 
with distilled water, and optical absorbance spectrum was measured using Jasco V-670 13 
spectrophotometer (Tokyo, Japan). The absorbance spectrum showed a peak at 260 nm and a 14 
trough at 230 nm in UV region, which are characteristics of the absorbance of DNA. Then, the 15 
amount of CpG DNA contained in SWCNTs suspension was calculated from the absorbance 16 
difference between at 260 nm and at 230 nm. 17 
2.6 Evaluation of microscopic characterization of SWCNT/CpG DNA complex 18 
  
8 
The SWCNT/CpG DNA complex was centrifuged for 155 minutes at 284,000 g to remove 1 
any insoluble material. Then, the supernatant was filtered through a 30-kDa molecular weight 2 
filter (Amicon), and extensively washed several times with 5 ml of 5% dextrose to remove any 3 
unbound CpG DNA. The absorption spectra of the SWCNT/CpG DNA complex were analyzed 4 
using a Perkin-Elmer Lambda 900 UV/Vis/NIR spectrometer. Luminescence spectra of the 5 
SWCNT/CpG DNA complex were analyzed using a SHIMADZU NIR-PL System. AFM images 6 
were analyzed using an Asylum Technology MFP-3D-SA. 7 
2.7 Temperature increase of SWCNT/CpG DNA complex solutions by NIR laser 8 
irradiation  9 
The SWCNT/CpG DNA complex was suspended at concentrations of 10 g of 10 
SWCNTs/ml or 20 g of SWCNTs/ml in 48-well plates. Two hundred microliters of each 11 
suspension was irradiated at 2 W/cm
2
 or 3 W/cm
2
 for 5 minutes by using an 808-nm NIR laser 12 
(Chameleon-RF, Coherent Japan Inc., Tokyo, Japan). The temperature was measured using a 13 
thermocouple. 14 
2.8 Evaluation of cancer cell ablation induced by SWCNT/CpG DNA complex with NIR 15 
laser irradiation in vitro 16 
The SWCNT/CpG DNA complex (1g of SWCNTs) or naked CpG DNA (2g) were 17 
added to colon 26 cells (1×10
4
) and incubated for 24 hours. Then, the cells were washed three 18 
  
9 
times with PBS, and exposed to 808 nm of NIR laser for 2 minutes at 5 W/cm
2
. Cell death was 1 
assessed using a Live-Dead-Cell Staining Kit (BioVision Inc., California, USA). 2 
2.9 Evaluation of temperature increase and HSP70 production induced by SWCNT/CpG 3 
DNA complex with NIR laser irradiation in vivo 4 
Colon 26 cells (3×10
5
) were transplanted into the flanks of mice (n=5 for each group). Once 5 
the tumors reached a mean diameter of 5 mm, 5% of dextrose, naked CpG DNA (10 g), the 6 
SWCNT/CpG DNA complex (1 g of SWCNTs and 10 g of CpG DNA) or the SWCNT/GpC 7 
DNA complex (1 g of SWCNTs and 10 g of GpC DNA) were intratumorally injected into the 8 
mice. Then, 5% of dextrose, naked CpG DNA (10 g) and the SWCNT/CpG DNA complex 9 
treated groups were divided into NIR laser irradiated and non-NIR laser irradiated groups. For 10 
the NIR laser irradiated groups, 24 hours after administration, the tumors were irradiated with 11 
NIR laser 3 times of 30 s-on and 30 s-off once daily for 3 days. Tumor tissues were collected at 12 
different time points and HSP70 production levels were measured using a HSP70 ELISA kit 13 
(Enzo Life Sciences Inc., New York, USA). The temperature increase of the tumor tissues was 14 
monitored using an InfReC Thermography R300 (NEC Avio Infrared Technologies Co., Ltd, 15 
Tokyo, Japan) after NIR laser irradiation for 30 s. 16 
2.10 Evaluation of cytokine production in tumor tissues and serum after SWCNT/CpG 17 
DNA complex intratumoral injection 18 
  
10 
Colon 26 cells (3×10
5
) were transplanted into the flanks of mice (n=5 for each group). Once 1 
the tumors reached a mean diameter of 5 mm, naked CpG DNA (10 g), the SWCNT/CpG DNA 2 
complex (1 g of SWCNTs and 10 g of CpG DNA) or the SWCNT/GpC DNA complex (1 g 3 
of SWCNTs and 10 g of GpC DNA) were intratumorally injected into the mice. Then, 2 hours 4 
later, tumor tissues and the serum were collected. Then, inflammatory cytokines including TNF-5 
, IL-12p70 and IL-6 productions were measured with a BD Cytometric Bead Array (CBA) 6 
Mouse Inflammation Kit (Becton, Dickinson and Company, Tokyo, Japan) by using a BD 7 
FACSCantoTM II Flow Cytometer (Becton, Dickinson and Company, Tokyo, Japan). 8 
2.11 Evaluation of cytokine enhancement in tumor tissues induced by SWCNT/CpG DNA 9 
complex after NIR laser irradiation 10 
The SWCNT/CpG DNA complex (1 g of SWCNTs and 10 g of CpG DNA) was 11 
intratumorally injected into mice. Then, the SWCNT/CpG DNA complex treated mice were 12 
divided into NIR laser irradiated and non-NIR laser-irradiated groups. For the NIR laser 13 
irradiated groups, 24 h after administration, tumors were irradiated with NIR laser three times at 14 
30-s-on and 30-s-off bursts once daily for 3 days. The tumor tissues were collected at 6 hours 15 
after the last NIR laser irradiation and cytokines including TNF-, IL-12p70 and IL-6 16 
productions were measured using a BD Cytometric Bead Array (CBA) Mouse Inflammation Kit.  17 




Colon 26 cells (3×10
5
) were transplanted into the flanks of mice. Once the tumors reached a 1 
mean diameter of 5 mm, naked CpG DNA (10 g), the SWCNT/CpG DNA complex (1 g of 2 
CNT and 10 g of CpG DNA), or the SWCNT/GpC DNA complex (1 g of CNT and 10 g of 3 
GpC DNA) were intratumorally injected into the mice. Then, 24 hours later, NIR laser was 4 
irradiated (30 s on and 30 s off for 3 times) for 3 days. The tumor sizes were measured up to 62 5 
days after the transplantation of the colon 26 cells.  6 
 7 
3. Results and Discussion 8 
3.1 Characterization of SWCNT/CpG DNA complexes 9 
CNTs have various possible applications in nanomedicine. However, such potential 10 
biological applications of CNTs will require improvements to be made to the dispersibility 11 
and/or solubility of CNTs in aqueous solution. Several papers have reported that wrapping of the 12 
CNTs by DNA was found to be sequence-dependent (Zheng et al., 2003b), especially in the case 13 
of Poly (T), which has the highest dispersion efficiency among fixed length homopolymers 14 
(Zheng et al., 2003a). Other combinations of DNA sequence motifs such as d(GT)n or d(AC)n 15 
were also investigated (Vogel et al., 2007). However, the interaction of CNTs with CpG DNA is 16 
less well studied. In this study, 1 mg of HiPco SWCNTs and 5 mg of CpG DNA were sonicated 17 
in 5 ml of 5% dextrose solution for 20 minutes in an ice-water bath to form SWCNT/CpG DNA 18 
complexes. Microscopic characterizations of the resultant SWCNT/CpG DNA complexes were 19 
  
12 
analyzed by UV/Visible-NIR absorption spectroscopy (Fig. 1a), photoluminescence 1 
spectroscopy (Fig. 1b), and atomic force microscopy (AFM) (Fig. 1c). The SWCNT/CpG DNA 2 
complexes were dispersed individually without the formation of remarkable aggregates, as 3 
evidenced by the appearance of a high peak in the absorption spectra (Fig. 1a,). As the 4 
photoluminescence isn't observed for aggregates but only for individualized SWCNTs, the strong 5 
fluorescence in the photoluminescence spectra (Fig. 1b) indicated that well dispersed SWCNTs 6 
were present. However, this result could not rule out the presence of some bundles. Meanwhile, 7 
AFM images clearly showed that the SWCNT/CpG DNA complexes were well dispersed and 8 
had a mean diameter of about 1–4 nm (Fig. 1c) and hight of about 0.5-2 nm (Fig. 1d). In addition, 9 
removal of free DNA by a 30-kDa molecular weight filter did not cause SWCNT flocculation to 10 
occur, and the resultant SWCNT/CpG DNA complexes were stable for months at 4 °C. The 11 
SWCNT/CpG DNA complexes were also redispersed in 5% dextrose solution once freeze-dried, 12 
indicating that the CpG DNA binding to the SWCNTs was very strong. Furthermore, the amount 13 
of CpG DNA contained in SWCNTs suspension was calculated from the absorbance difference 14 
between at 260 nm and at 230 nm, and determined to be 1.27 ± 0.24 ug/1 ug SWCNTs. Taegar 15 
and collaborators have reported that the best dispersion efficiency is achieved at DNA: CNT 16 
ratios of 1:1 or 1:2 (Taegar et al., 2005). Our result was comparable with their result. The 17 
fragmentation of CpG DNA was not achieved by sonication for 20 minutes (Fig. S1a). The 18 
fragmentation of CpG DNA by sonication in the presence of SWCNTs was also checked. The 19 
results were showed in Fig. S2b. The concentration of CpG DNA which by the sonication with 20 
  
13 
SWCNTs were slightly decreased compared with CpG DNA that were not sonicated. However, 1 
Large fragment of CpG DNA in SWCNT/CpG DNA complex were not detected. We considered 2 
that during the preparation of SWCNT/CpG DNA complex, SWCNTs may have litter effect on 3 
CpG DNA fragmentation. Moreover, in vitro studies showed that the sonicated CpG DNA 4 
maintained an equivalent immunostimulatory potential to that of CpG DNA prior to sonication 5 
(Fig. S1c). These results suggested that CpG DNA may still exhibit immunostimulatory activity 6 
after sonication. 7 
3.2 In vitro and in vivo photohyperthermic effects of SWCNT/CpG DNA complexes with 8 
NIR irradiation  9 
Supratim et al. recently demonstrated that DNA-encased CNTs are efficient for thermal 10 
ablation (Ghosh et al., 2009). To investigate whether the SWCNT/CpG DNA complexes also 11 
keep the photohyperthermic effect by NIR laser irradiation, the temperature increases achieved 12 
following NIR laser irradiation of the SWCNT/CpG DNA complexes were evaluated. In Fig. 2, 13 
when a SWCNT/CpG DNA complex solution was irradiated with a NIR laser at 3 W/cm
2
 (Fig. 14 
2b), the temperature increased more rapidly than irradiation at 2 W/cm
2
 (Fig. 2a). Additionally, 15 
the increases in temperature of the SWCNT/CpG DNA complex solution were dependent on the 16 
concentration of SWCNTs in solution and the NIR laser irradiation time. Moreover, the 17 
photohyperthermic effect of the SWCNT/CpG DNA complexes was equal to the 18 
photohyperthermic effect of SWCNT/GpC DNA complexes (in which the SWCNTs dispersed 19 
  
14 
with GpC DNA exhibited no immunostimulatory effects), and SWCNT/Pluronic F-127 (in which 1 
the SWCNTs were dispersed with the surfactant, Pluronic F127) (Fig. 2c). These results suggest 2 
that the SWCNT/CpG DNA complexes also exhibit a thermal effect when irradiated with an NIR 3 
laser, thereby highlighting their potential use for photohyperthermic therapy. 4 
As the SWCNT/CpG DNA complexes released substantial vibrational energy after exposure 5 
to NIR light, the use of NIR irradiation for the induction of hyperthermia is particularly attractive 6 
because living tissues do not strongly absorb in this range (Weissleder, 2001). Therefore, a 7 
number of biomedical investigations of CNTs have focused on their application for the treatment 8 
of cancer (Liu et al., 2008a; Meng et al., 2008; Singh et al., 2005). In this study, the results of an 9 
in vitro photohyperthermic ablation of the murine colorectal cancer cell line, colon 26, treated 10 
with the SWCNT/CpG DNA complex, using NIR irradiation, were evaluated with a Live-Dead-11 
Cell Kit. It was shown that most of the colon 26 cells treated with the SWCNT/CpG DNA 12 
complex (1 g of SWCNTs) were dead after NIR laser irradiation (Fig. 3f), as compared with the 13 
same cells treated with the SWCNT/CpG DNA complex without NIR laser irradiation (Fig. 3e). 14 
Meanwhile, the untreated (NT) cells (Fig. 3b) and naked CpG DNA treated cells (Fig. 3d) 15 
survived even after receiving NIR laser irradiation. These results suggested that the 16 
SWCNT/CpG DNA complex induced colon 26 cell cytotoxicity after NIR laser irradiation.  17 
Moreover, we also investigated the photohyperthermic effects of the SWCNT/CpG DNA 18 
complex in vivo by evaluating the temperature increases and the production of HSP70 in tumor 19 
  
15 
tissue after NIR laser irradiation. HSPs are induced by elevated temperatures (typically in excess 1 
of 43 °C) and serve as endogenous cellular markers of thermal stress (Burke et al., 2009). As 2 
seen in Fig. 4a, after 30 s of NIR laser irradiation, the temperature of the tumor tissues treated 3 
with the SWCNT/CpG DNA complex or the SWCNT/GpC DNA (not immunostimulatory) 4 
complex were increased approximately up to 43 °C. On the other hand, the temperature of the 5 
tumor tissues treated with 5% dextrose or naked CpG DNA remained the same as the 6 
temperature before NIR laser irradiation. Then, we evaluated the production of HSP70 in tumor 7 
tissue after NIR laser irradiation. As shown in Fig. 4b, HSP70 production in the tumor tissues of 8 
mice treated with the SWCNT/CpG DNA complex + NIR were significantly higher than that in 9 
mice treated only with the SWCNT/CpG DNA complex at 6 hours after NIR laser irradiation (P 10 
< 0.01). In addition, in the tumor treated with the SWCNT/GpC DNA  complex + NIR laser, the 11 
HSP70 production was induced to a high level (Fig. 4c). In contrast, the HSP70 production in 12 
mice treated with 5% dextrose or naked CpG DNA was of a comparable level to that in the mice 13 
that did not receive NIR laser irradiation (Fig. 4c). These results suggest that both SWCNT 14 
complexes when stimulated with NIR laser irradiation increased the temperature in the tumor 15 
tissue and induced the enhancement of HSP70 production. 16 
3.3 Immune effect of SWCNT/CpG DNA complexes in tumor-bearing mice 17 
CpG DNA can be taken up by macrophages and dendritic cells, leading to the production of 18 
Th1-type cytokines such as IFN-γ (Krieg, 2002). In our previous studies, we have demonstrated 19 
  
16 
that CpG DNA Lipoplex showed strong immune responses and were effective in preventing 1 
proliferation of cancer cells (Kuramoto et al., 2009, 2008; Zhou et al., 2012, 2010). Therefore, 2 
using CpG DNA to disperse the SWCNTs may lead to complexes having an immunostimulatory 3 
effect. In this study, the immunoreactivity of the SWCNT/CpG DNA complex was evaluated by 4 
measuring the production of inflammatory cytokines in serum and in the tumor tissues in colon 5 
26 bearing mice at different time points (Fig. S3-S4). After intratumoral injection of the 6 
SWCNT/CpG DNA complex, the production of TNF- and IL-6 in the serum and the tumor 7 
tissues showed a peak value at 2 hours after administration (Fig. S3a, S3b, S4a and S4b). The 8 
production of IL-12p70 showed a peak value in the serum at 8 hours after administration (Fig. 9 
S3c) and in the tumor tissues at 2 hours after administration (Fig. S4c).  10 
In addition, compared with untreated mice or mice injected with naked CpG DNA or the 11 
SWCNT/GpC DNA complex, mice injected with the SWCNT/CpG DNA complex significantly 12 
induced higher levels of TNF- and IL-6 production both in serum (Fig. 5a and 5b) and in tumor 13 
tissue (Fig.6a and 6b) at 2 hours after injection. The SWCNT/CpG DNA complex also induced 14 
higher levels of IL-12p70 production in tumor tissues than compared with either naked CpG 15 
DNA or the SWCNT/GpC DNA complex (Fig. 5c). These results demonstrated that the 16 
SWCNT/CpG DNA complex induced TNF- and IL-6 cytokine production in tumor tissues and 17 
in serum, and may have the potential to inhibit tumor growth. As several papers have already 18 
demonstrated that CNTs are able to enter immune cells such as macrophages actively and 19 
  
17 
passively via incomplete phagocytosis or by impaling the membrane (Cheng et al., 2009; Kam et 1 
al., 2005; Kraszewski et al., 2012), we considered that the SWCNT/CpG DNA complex may be 2 
more effectively recognized by the immune cells than naked CpG DNA. Moreover, our results 3 
suggest that the SWCNT/CpG DNA complex induced higher levels of cytokine production than 4 
naked CpG DNA, thereby confirming the reports that functionalized CNTs could enhance CpG 5 
DNA uptake and their immunostimulatory properties (Bianco et al., 2005b; Zhao et al., 2011). 6 
Furthermore, Fan et al. also has reproted that functionalized carbon nanotubes that conjugated 7 
with CpG DNA enhanced activity of CpG DNA and was effective for both brain and systemic 8 
melanomas (Fan et al., 2012). 9 
As some reports have shown that the photohyperthermic effect could enhance immune 10 
responses in vivo (Zhang et al., 2008; Gastpar et al., 2005), next, we investigated the immune 11 
effects of the SWCNT/CpG DNA complex after NIR laser irradiation. The results showed that 12 
there was no significant difference between the cytokine production levels of the SWCNT/CpG 13 
DNA complex and the SWCNT/CpG DNA complex + NIR laser irradiation (data not shown). 14 
This result may be because the photohyperthermic effects induced by the SWCNT/CpG DNA 15 
complex + NIR were either not enough to enhance the immune response, or the enhanced 16 
immune response was too low to be detected. We will investigate these details in the future.  17 




Then, the antitumor effect of the SWCNT/CpG DNA complex was also evaluated in tumor-1 
bearing mice. For this study, 3×10
5
 colon 26 cells were subcutaneously injected into the flanks of 2 
the tumor-bearing mice. Once the tumor volumes reached approximately 200 mm
3
, the mice 3 
were injected intratumorally with 50l of treatment solution, which contained 10g of either 4 
naked CpG DNA, the SWCNT/CpG DNA complex (1 g of SWCNTs and 10 g of CpG DNA) 5 
or the SWCNT/GpC DNA complex, which are not immunostimulatory (1g of SWCNTs and 10 6 
g of GpC DNA). (n = 6 per group). It was found that there was no statistical differences among 7 
the group mean tumor volumes of the three solutions tested at the onset of treatment. After 8 
treatment, compared with the untreated (NT), the NIR laser-only, and the SWCNT/GpC DNA 9 
complex + NIR studies, the tumor volumes of the SWCNT/CpG DNA complex + NIR treated 10 
mice had decreased significantly by day 24 (P < 0.001 compared with the NT and NIR laser – 11 
only; P < 0.01 compared with the SWCNT/GpC DNA complex + NIR) and by day 26 (P < 0.001 12 
compared with NT; P < 0.01 compared with NIR laser – only; P < 0.05 compared with the 13 
SWCNT/GpC DNA complex + NIR) after tumor cell implantation (Fig. 7). Moreover, the 14 
SWCNT/CpG DNA complex + NIR treated mice were even significantly decreased compared 15 
with naked CpG DNA or naked CpG DNA + NIR treated mice (P < 0.05) (Fig. 7). The tumor 16 
volumes of the SWCNT/CpG DNA complex + NIR treated mice were smaller than that of the 17 
SWCNT/CpG DNA complex treated mice, albeit a minor difference. These results demonstrated 18 
that the combination of SWCNT/CpG DNA complex administration and NIR laser irradiation 19 
  
19 
led to a more efficient antitumor effect than compared with that achieved by naked CpG DNA 1 
administration or SWCNT/GpC DNA complex administration.  2 
Several papers have reported that CNTs are effective in photohyperthermic therapy (Burke 3 
et al., 2009; Ghosh et al., 2009; Xiao et al., 2009). An advantage of NIR is that biological 4 
systems largely lack chromophores that absorb in this region, and as such, the NIR light should 5 
effectively and safely penetrate normal tissue and ablate any cells to which the CNTs are 6 
attached. Moreover, hyperthermic therapy has been clinically used in the management of solid 7 
tumors because it can synergistically enhance tumor cytotoxicity when combined with 8 
chemotherapy or radiotherapy (Falk and Issels, 2001; Wust et al., 2002). However, the 9 
combination of immunotherapy with CNTs is less well studied. In the present study, we 10 
successfully combined the photohyperthermic effects and immune effects together using the 11 
SWCNT/CpG DNA complex, and observed the resultant antitumor effect in vivo (Fig. 7). In 12 
practice, the toxicology of SWCNTs also needs to be addressed prior to using them in clinical 13 
situations. It has been found that well-functionalized CNTs, which are stable in physiological 14 
environments, are non-toxic to cells in vitro and non-toxic to mice in vivo (Liu et al., 2009; Liu 15 
et al., 2008; Schipper et al., 2008; Yang et al., 2008). Furthermore, Kagan et al. recently showed 16 
that hypochlorite and reactive radical intermediates of the human neutrophil enzyme, 17 
myeloperoxidase, enhance the biodegradation of SWCNTs in vitro, in neutrophils, and to a lesser 18 
  
20 
degree, in macrophages (Kagan et al., 2010). Therefore, the SWCNT/CpG DNA complex may 1 
be applied for effective cancer immunotherapy without significant toxicity. 2 
4. Conclusions 3 
We successfully prepared the SWCNTs / CpG DNA complexes, which were dispersed well 4 
and possessed both the photohyperthemic effects and the immune effects. The SWCNTs / CpG 5 
DNA complexes enhanced the production level of inflammatory cytokines in tumor tissues when 6 
intratumoral administration. We also have shown an effective combination cancer therapy using 7 
SWCNTs / CpG DNA complexes in mice. Intratumoral administration of SWCNTs / CpG DNA 8 
complexes with NIR irradiation prevented the proliferation of tumor growth in mice and 9 
prolonged the survival time of mice. These were suggested that combination of 10 
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Figure 1. Characterization of the SWCNT/CpG DNA complex. (a) UV-Vis-NIR absorption 3 
spectra of the SWCNT/CpG DNA complex. (b) Photoluminescence maps of the SWCNT/CpG 4 
DNA complex. (c) AFM images of the SWCNT/CpG DNA complex. (d) Height of 5 
SWCNT/CpG DNA complex in AFM images. Results are representative of three experiments. 6 
Figure 2. Temperature increases of the SWCNT/CpG DNA complex through NIR laser 7 
irradiation. SWCNT/CpG DNA complex solutions were prepared at two concentrations (10 g 8 
CNT/ml and 20 g CNT/ml) and placed in 48-well plates. Each sample was then irradiated with 9 
an 808-nm NIR laser at a different power level—(a) power level 2W/cm2, (b) power level 10 
3W/cm
2—for 5 minutes. The temperatures were measured every 20 s. (c) Temperature increases 11 
of the SWCNT/CpG DNA complex, the SWCNT/GpC DNA complex, and the SWCNT /F-127 12 
after NIR laser irradiation. Results are representative of three experiments. 13 
Figure 3. In vitro photohyperthermic effects of the SWCNT/CpG DNA complex. The viabilities 14 
of colon 26 cells treated with naked CpG DNA or the SWCNT/CpG DNA complex following 15 
NIR laser irradiation were examined using a Live-Dead-Cell Kit. The representative images from 16 
each sample are shown. Cells with green fluorescence were considered alive, whereas those with 17 
red fluorescence were dead. (a) Untreated colon 26 cells. (b) Untreated colon 26 cells + NIR 18 
laser. (c) Colon 26 cells treated with CpG DNA alone. (d) Colon 26 cells treated with CpG DNA 19 
  
32 
+ NIR. (e) Colon 26 cells treated with the SWCNT/CpG DNA complex. (f) Colon 26 cells 1 
treated with the SWCNT/CpG DNA complex + NIR. Results are representative of more than 2 
three experiments. 3 
Figure 4. Temperature increases and HSP70 production induced by NIR laser irradiation of the 4 
SWCNT/CpG DNA complex in vivo. (a) Temperature increases in tumor tissues after NIR laser 5 
irradiation. (b) HSP70 production induced by NIR laser irradiation of the SWCNT/CpG DNA 6 
complex in tumor tissues at different time points. * P < 0.05 compared with SWCNT/CpG DNA 7 
complex + NIR at 2 hours after NIR laser irradiation. ** P < 0.01 compared with SWCNT/CpG 8 
DNA complex at 6 hours, and SWCNT/CpG DNA complex + NIR at 24 hours after NIR laser 9 
irradiation. (c) HSP70 production induced by NIR laser irradiation of 5% dextrose, naked CpG 10 
DNA, the SWCNT/CpG DNA complex or the SWCNT/GpC DNA complex in tumor tissue at 6 11 
hours after NIR laser irradiation. * P < 0.05 compared with 5% dextrose and the SWCNT/CpG 12 
DNA complex; ** P < 0.01 compared with 5% dextrose + NIR and naked CpG DNA + NIR. # P 13 
< 0.05 compared with 5% dextrose + NIR, naked CpG DNA + NIR, and the SWCNT/CpG DNA 14 
complex. Each value represents the mean + S. D. (n = 5). Results are representative of three 15 
experiments. 16 
Figure 5. Cytokine productions induced by the SWCNT/CpG DNA complex in tumor tissue. (a) 17 
TNF- production levels in tumor tissues after naked CpG DNA, SWCNT/CpG DNA complex 18 
or SWCNT/GpC DNA complex administration. * P < 0.05 compared with NT and SWCNT/GpC 19 
  
33 
DNA complex. (b) IL-6 production levels in tumor tissues after naked CpG DNA, SWCNT/CpG 1 
DNA complex or SWCNT/GpC DNA complex administration. * P < 0.05 compared with naked 2 
CpG DNA; ** P < 0.01 compared with NT and the SWCNT/GpC DNA complex. (c) IL-12p70 3 
production levels in tumor tissues after naked CpG DNA, SWCNT/CpG DNA complex or 4 
SWCNT/GpC DNA complex administration. Each value represents the mean + S. D. (n = 5-6). 5 
Results are representative of more than three experiments. 6 
 7 
Figure 6. Cytokine productions induced by the SWCNT/CpG DNA complex in serum. (a) TNF-8 
 production levels in serum after naked CpG DNA, SWCNT/CpG DNA complex or 9 
SWCNT/GpC DNA complex administration. * P < 0.05 compared with NT and the 10 
SWCNT/GpC DNA complex. (b) IL-6 production levels in serum after naked CpG DNA, 11 
SWCNT/CpG DNA complex or SWCNT/GpC DNA complex administration. ** P < 0.01 12 
compared with NT, naked CpG DNA and the SWCNT/GpC DNA complex. Each value 13 
represents the mean + S. D. (n = 5-6). Results are representative of more than three experiments. 14 
 15 
Figure 7. Tumor volume of mice after combination of SWCNT/CpG DNA complex intratumoral 16 
administration and NIR laser irradiation. # P < 0.05 compared with naked CpG DNA and naked 17 
CpG DNA + NIR; ## P < 0.01 compared with SWCNT/GpC DNA +NIR; ### P < 0.001 18 
  
34 
compared with NT and NIR laser - only; * P < 0.05 compared with SWCNT/GpC DNA +NIR; 1 
** P < 0.01 compared with NIR laser - only; *** P< 0.001 compared with NT. Each value 2 
represents the mean + S. D. (n = 6). Results are representative of more than three experiments. 3 
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